IP Library Granted Patent US 8,364,228
Granted Patent B2
US 8,364,228 · App. 11/721,287 · Granted Jan 29, 2013

Appartus and method for continuous real-time trace biomolecular sampling, analysis, and delivery

Inventors: John Frederick Currie (Bethesda, MD); Makarand Paranjape (Silver Spring, MD)
Assignee: Flexible Medical Systems, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,364,228
App. No.
11/721,287
Granted
Jan 29, 2013
Kind
B2
Abstract

A system and method for transdermal sampling wherein at least one pair of sample electrodes is adapted to provide voltage pulses capable of creating capillary openings in a subject's stratum corneum. Methods for using a transdermal sampling system by creating capillary openings in a subject's stratum corneum via the application of a series of voltage pulses to the stratum corneum and contacting at least a portion of at least one of the sample electrodes with interstitial fluid from the capillary openings are also presented.

Claims (44)

1. A device for transdermal sampling comprising:

a flexible substrate;

at least one pair of sample electrodes disposed on the flexible substrate;

an anchor layer covering at least a portion of at least one pair of sample electrodes;

a first pair of electrically conductive paths coupled to the at least one pair of sample electrodes;

a second pair of electrically conductive paths; and

at least one resistive element coupled to the second pair of electrically conductive paths, wherein:

the at least one resistive element is disposed proximate to the at least one pair of sample electrodes and configured to provide a sequence of thermal heating to generate a temperature sufficient to disrupt stratum corneum cells of a subject without damaging the stratum corneum cells to thereby allow interstitial fluid to pass through capillary openings formed through the stratum corneum cells and into contact with the at least one pair of sample electrodes.

2. The device according to claim 1 , wherein the anchor layer comprises an enzyme.

3. The device according to claim 2 , wherein the enzyme is selected from the group consisting of glucose oxidase and lactate oxidase.

4. The device according to claim 1 , wherein the at least one resistive element has a resistance of about 50 Ohms to about 200 Ohms.

5. The device according to claim 1 , wherein the sequence of thermal heating are created by applying voltage pulses to the at least one resistive element that are about 2 volts or less and for less than about 1 second.

6. The device according to claim 1 , wherein the flexible substrate comprises a cavity and the interstitial fluid is collected into the cavity.

7. The device according to claim 6 , wherein the at least one pair of sample electrodes are at least partially disposed in the cavity.

8. The device according to claim 1 , wherein the flexible substrate comprises a polymer.

9. The device according to claim 1 , wherein the flexible substrate comprises a multilayer polymeric metal laminate structure.

10. A method for transdermal sampling comprising:

affixing a device for transdermal sampling to the stratum corneum layer of a subject, wherein the device for transdermal sampling comprises:

a flexible substrate;

at least one pair of sample electrodes disposed on the flexible substrate;

an anchor layer covering at least a portion of at least one pair of sample electrodes;

a first pair of electrically conductive paths coupled to the at least one pair of sample electrodes;

a second pair of electrically conductive paths; and

at least one resistive element coupled to the second pair of electrically conductive paths, wherein:

the at least one resistive element is disposed proximate to the at least one pair of sample electrodes and configured to provide a sequence of thermal heating to generate a temperature sufficient to disrupt stratum corneum cells of a subject without damaging the stratum corneum cells to thereby allow interstitial fluid to pass through capillary openings formed through the stratum corneum cells and into contact with the at least one pair of sample electrodes; and

applying voltage pulses to the at least one resistive element via the second pair of electrically conductive paths to generate the temperature sufficient to disrupt the stratum corneum cells, wherein the voltage pulses are about 2 volts or less and are of a duration of 1 second or less.

11. The method according to claim 10 , wherein the anchor layer comprises an enzyme.

12. The method according to claim 11 , wherein the enzyme is selected from the group consisting of glucose oxidase and lactate oxidase.

13. The method according to claim 10 , wherein the at least one resistive element has a resistance of about 50 Ohms to about 200 Ohms.

14. The method according to claim 10 further comprising:

measuring an electrical property generated across at least one pair of sample electrodes; and

correlating the measured electrical property to a biological condition.

15. The method according to claim 14 , further comprising

delivering a material from a cavity within the device for transdermal sampling to the interstitial fluid.

16. The method according to claim 15 , further comprising analyzing the interstitial fluid for efficacy of the material.

17. The method according to claim 14 , further comprising:

determining whether the correlated biological condition is normal; and

generating a signal when the correlated biological condition is abnormal.

18. The method according to claim 17 , wherein the determining whether the correlated biological condition is normal comprises comparing the correlated biological condition to a normal healthy baseline condition.

19. The method according to claim 14 , wherein the biological condition is related to the amount of a targeted bio-molecule present in the interstitial fluid, wherein the targeted bio molecule is selected from the group consisting of glucose and lactate.

20. The method according to claim 14 , wherein the electrical property is current.

21. The method according to claim 10 further comprising:

controlling the application of voltage pulses with a controller; and

communicating information between the controller and a remote device.

Assignments (9)
CHANGE OF NAME Recorded May 11, 2023
From: CLINITECH, LLC
To: CAMBRIDGE MEDICAL TECHNOLOGIES LLC
Reel/Frame 063610/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2016
From: TOUCHTEK LABS, LLC
To: FLEXIBLE MEDICAL SYSTEMS, LLC
Reel/Frame 040723/0824 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 13, 2016
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: CLINITECH, LLC
Reel/Frame 040724/0128 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE INFORAMTION PREVIOUSLY RECORDED ON REEL 032717 FRAME 0146. ASSIGNOR(S) HEREBY CONFIRMS THE THE ONLY ASSIGNEE SHOULD BE TOUCHTEK LABS, LLC, 15601 CRABBS BRANCH WAY, DERWOOD, MARYLAND 20855. Recorded Jun 10, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: TOUCHTEK LABS, LLC
Reel/Frame 033119/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: TOUCHTEK LABS, LLC
Reel/Frame 032868/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: MEDINA ISF EQUITY, LLC; FLEXIBLE MEDICAL SYSTEMS LLC; TOUCHTEK LABS, LLC
Reel/Frame 032717/0146 →
RELEASE OF SECURITY INTEREST Recorded Aug 30, 2011
From: FISH & RICHARDSON P.C.
To: FLEXIBLE MEDICAL SYSTEMS, LLC
Reel/Frame 026830/0322 →
STATEMENT OF A LIEN Recorded Jan 26, 2010
From: FLEXIBLE MEDICAL SYSTEMS, LLC
To: FISH & RICHARDSON P.C.
Reel/Frame 023852/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2008
From: CURRIE, JOHN FREDERICK
To: FLEXIBLE MEDICAL SYSTEMS, LLC
Reel/Frame 021192/0762 →
Continuity (1)
Related Publication 20090281404A1 · Nov 12, 2009